Literature DB >> 27914950

Access to medications for medicare enrollees related to race/ethnicity: Results from the 2013 Medicare Current Beneficiary Survey.

Deborah A Taira1, Chengli Shen2, Marshaleen King3, Doug Landsittel2, Mary Helen Mays4, Tetine Sentell5, Janet Southerland6.   

Abstract

BACKGROUND: Prescription medications are taken by millions of Americans to manage chronic conditions and treat acute conditions. These medications, however, are not equally accessible to all.
OBJECTIVE: To examine medication access by race/ethnicity among Medicare beneficiaries.
METHODS: Using the 2013 Medicare Current Beneficiary Survey (n = 10.515), this study examined access to medications related to race/ethnicity, comparing non-Hispanic blacks and Hispanics to whites. Multivariable logistic regression models were estimated, controlling for age, gender, income, education, chronic conditions, and type of drug coverage.
RESULTS: Non-Hispanic blacks were less satisfied than whites with amount paid for prescriptions [OR = 0.69,95%CI(0.55,0.86)], the list of drugs covered by their plan [OR = 0.69,95%CI(0.56,0.85)], and finding a pharmacy that accepts their drug coverage [OR = 0.59,95%CI(0.48,0.72)], after adjustment. Low-income individuals were more likely to report not filling a prescription and taking less medication than prescribed. Compared to beneficiaries with excellent health, those with poor, fair, or good health were less satisfied with access. Access was also diminished for patients with depression, diabetes, and chronic obstructive pulmonary disease, emphysema or asthma.
CONCLUSION: Possible interventions for non-Hispanic blacks might include assisting them in finding the best drug plan to meeting their needs, connecting them to medication assistance programs, and discussing convenience of pharmacy with patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Access to care; Medicare; Medication adherence; Race/ethnicity

Mesh:

Substances:

Year:  2016        PMID: 27914950      PMCID: PMC5500432          DOI: 10.1016/j.sapharm.2016.10.021

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  20 in total

1.  Public and private pharmaceutical spending as determinants of health outcomes in Canada.

Authors:  Pierre-Yves Crémieux; Marie-Claude Meilleur; Pierre Ouellette; Patrick Petit; Martin Zelder; Ken Potvin
Journal:  Health Econ       Date:  2005-02       Impact factor: 3.046

Review 2.  The effects of pharmaceutical consumption and obesity on the quality of life in the organization of economic cooperation and development (OECD) countries.

Authors:  H E Frech; Richard D Miller
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001.

Authors:  Frank R Lichtenberg
Journal:  Int J Health Care Finance Econ       Date:  2005-03

4.  The value of antihypertensive drugs: a perspective on medical innovation.

Authors:  David M Cutler; Genia Long; Ernst R Berndt; Jimmy Royer; Andrée-Anne Fournier; Alicia Sasser; Pierre Cremieux
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

Review 5.  A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.

Authors:  J W Williams; C D Mulrow; E Chiquette; P H Noël; C Aguilar; J Cornell
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

6.  The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

7.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

8.  Early hospital readmission is a predictor of one-year mortality in community-dwelling older Medicare beneficiaries.

Authors:  Hillary D Lum; Stephanie A Studenski; Howard B Degenholtz; Susan E Hardy
Journal:  J Gen Intern Med       Date:  2012-06-13       Impact factor: 5.128

9.  Variation in Specialty Outpatient Care Patterns in the Medicare Population.

Authors:  Jeffrey D Clough; Kavita Patel; William H Shrank
Journal:  J Gen Intern Med       Date:  2016-06-03       Impact factor: 5.128

10.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.

Authors:  Andy Menke; Sarah Casagrande; Linda Geiss; Catherine C Cowie
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

View more
  1 in total

1.  Differences in hospitalizations, emergency room admissions, and outpatient visits among Mexican-American Medicare beneficiaries.

Authors:  Brian Downer; Soham Al Snih; Lin-Na Chou; Yong-Fang Kuo; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  BMC Geriatr       Date:  2019-05-21       Impact factor: 3.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.